DIVIDEND ANNOUNCEMENT: Catalyst Biosciences Inc (NASDAQ:CBIO) on 12/27/2022 declared a dividend of $0.2400 per share

Catalyst Biosciences Inc (NASDAQ:CBIO) on 12/27/2022 declared a dividend of $ 0.2400 per share payable on January 12, 2023 to shareholders of record as of January 05, 2023. Dividend amount recorded is a decrease of $ 1.19 from last dividend Paid.

Catalyst Biosciences Inc (NASDAQ:CBIO) has paid dividends since 1970, has a current dividend yield of 0.0000000000% and has increased its dividends for 0 successive years.

Catalyst Biosciences Inc's market cap is $ 15,839,470 and has a PE ratio of 1.32. The stock price closed yesterday at $ 0.50 and has a 52 week low/high of $ 0.35 and $ 2.09.

Catalyst Biosciences is a research and clinical development biopharmaceutical company. Co.'s complement portfolio consists of the development candidates CB 4332 and CB 2782-PEG. CB 4332 is a wholly owned, improved albumin-fused Complement Factor I (CFI) molecule intended for prophylactic subcutaneous or intravitreal administration in individuals with an imbalance in complement homeostasis or a CFI deficiency. CB 2782-PEG is a potential component 3 degrader product candidate in preclinical development for the treatment of dry age-related macular degeneration. Co. has several engineered protease programs in discovery or early non-clinical development.

For more information on Catalyst Biosciences Inc click here.